Literature DB >> 17586241

Dissecting posterior inferior cerebellar artery aneurysm presenting with subarachnoid hemorrhage right after anticoagulant and antiplatelet therapy against ischemic event.

Ichiro Takumi1, Takayuki Mizunari, Masahiro Mishina, Takaharu Fukuchi, Ryutaro Nomura, Katsuya Umeoka, Shiro Kobayashi, Akira Teramoto.   

Abstract

BACKGROUND: Dissecting aneurysms with initial ischemic manifestations may present with subsequent subarachnoid hemorrhage (SAH), and their treatment is controversial. This is a case report that illustrates the dilemma when dealing with an immediate post-SAH period dissecting posterior inferior cerebellar artery (PICA) aneurysm initially presenting with an ischemic event.
METHODS: We present a 57-year-old man with a dissecting PICA aneurysm who had SAH right after anticoagulant and antiplatelet therapy for cerebral infarction. The aneurysm was not detected by magnetic resonance angiography performed at the time of admission.
RESULTS: On admission, he was treated with both anticoagulant and antiplatelet therapy. After the SAH episode, he underwent emergent resection of the dissecting aneurysm and left OA-PICA anastomosis.
CONCLUSION: If hemorrhagic transformation occurs at the site of an ischemic dissecting aneurysm, surgical or endovascular intervention should be considered immediately. Although the optimal treatment of dissecting aneurysms with ischemic onset remains controversial, anticoagulant and antiplatelet therapy should not be rejected out of hand.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17586241     DOI: 10.1016/j.surneu.2006.08.063

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  2 in total

1.  Management of posterior fossa dissecting aneurysms.

Authors:  W K Winston Chong
Journal:  Interv Neuroradiol       Date:  2009-01-02       Impact factor: 1.610

2.  Treatment of a cerebral dissecting aneurysm in anterior circulation: report of 11 subarachnoid hemorrhage cases.

Authors:  Hirofumi Oyama; Akira Kito; Hideki Maki; Kenichi Hattori; Tomoyuki Noda; Kentaro Wada
Journal:  Nagoya J Med Sci       Date:  2012-08       Impact factor: 1.131

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.